• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nanobiotix S.A. - ADSs (NQ:NBTX)

29.19 +3.36 (+13.01%)
Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 216,584
Open 26.74
Bid (Size) 29.19 (700)
Ask (Size) 44.19 (200)
Prev. Close 25.83
Today's Range 26.74 - 29.92
52wk Range 14.78 - 57.14
Shares Outstanding 34,432,122
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Voting Rights and Shares Capital of the Company
October 20, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer
October 01, 2026
From Nanobiotix S.A.
Via GlobeNewswire

Performance

52-Week Range 48.9% below 52-week high
29.19
14.7852W Low 57.1452W High
1 Week
20.701W Low 27.501W High

Nanobiotix S.A. - ADSs (NBTX) traded between $14.78 and $57.14 over the past 52 weeks and last traded at $29.19, 48.9% below its 52-week high. Over the past week it ranged between $20.70 and $27.50.

Past 12 Months
+31.3%
-15.4%
-27.7%
-9.3%
+31.9%
+29.0%
1W +$6.96
1M -$5.31
3M -$11.19
6M -$3.00
YTD +$7.06
1Y +$6.57

NBTX was +29.0% over the past year, -9.3% over six months, +31.9% year to date, +31.3% in the last week.

12 Months vs Market
NBTX
+29.0%
DIA
+12.5%
SPY
+13.8%
QQQ
+15.2%
IWM
+12.0%

Over the past 12 months NBTX returned +29.0% versus DIA (Dow) +12.5%, SPY (S&P 500) +13.8%, QQQ (Nasdaq 100) +15.2% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 1.46× 3-mo avg
Today 216,584 3-mo avg 148.5K
1W
108.4K
1M
143.3K
3M
148.5K
6M
121.4K
YTD
95.0K
1Y
89.0K

NBTX most recently traded 216,584 shares against a 3-month average daily volume of 148.5K.

More News

Read More
News headline image
NANOBIOTIX Provides First Half 2026 Operational and Financial Update
September 24, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Voting Rights and Shares Capital of the Company
September 22, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer
September 14, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 09, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch. ↗
August 31, 2026
Via The Motley Fool
News headline image
Voting Rights and Shares Capital of the Company
August 25, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Voting Rights and Shares Capital of the Company
July 30, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Voting Rights and Shares Capital of the Company
June 05, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
June 02, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Nanobiotix Joins the Euronext Tech Leaders Index
June 02, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
NANOBIOTIX Announces Closing of Global Offering
May 26, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
May 22, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
May 21, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
May 21, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
May 21, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Nanobiotix Announces Launch of Global Follow-On Offering
May 20, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
May 17, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
May 04, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
April 20, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
Voting Rights and Shares Capital of the Company
April 07, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
March 31, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
March 30, 2026
From Nanobiotix S.A.
Via GlobeNewswire
News headline image
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026
March 26, 2026
From Nanobiotix S.A.
Via GlobeNewswire

Frequently Asked Questions

Is Nanobiotix S.A. - ADSs publicly traded?
Yes, Nanobiotix S.A. - ADSs is publicly traded.
What exchange does Nanobiotix S.A. - ADSs trade on?
Nanobiotix S.A. - ADSs trades on the Nasdaq Stock Market
What is the ticker symbol for Nanobiotix S.A. - ADSs?
The ticker symbol for Nanobiotix S.A. - ADSs is NBTX on the Nasdaq Stock Market
What is the current price of Nanobiotix S.A. - ADSs?
The current price of Nanobiotix S.A. - ADSs is 29.19
When was Nanobiotix S.A. - ADSs last traded?
The last trade of Nanobiotix S.A. - ADSs was at 10/22/26 04:00 PM ET
What is the market capitalization of Nanobiotix S.A. - ADSs?
The market capitalization of Nanobiotix S.A. - ADSs is 1.01B
How many shares of Nanobiotix S.A. - ADSs are outstanding?
Nanobiotix S.A. - ADSs has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap